Aviso Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$713K Sell
1,451
-127
-8% -$68.9K 0.32% 71
2025
Q4
$915K Sell
1,578
-606
-28% -$343K 0.38% 56
2025
Q3
$1.06M Sell
2,184
-468
-18% -$218K 0.46% 55
2025
Q2
$1.08M Sell
2,652
-460
-15% -$192K 0.5% 50
2025
Q1
$1.55M Sell
3,112
-251
-7% -$136K 0.82% 32
2024
Q4
$1.75M Sell
3,363
-51
-1% -$28K 0.89% 29
2024
Q3
$2.11M Buy
3,414
+1,818
+114% +$1.08M 1.15% 20
2024
Q2
$883K Buy
1,596
+144
+10% +$82.5K 0.52% 48
2024
Q1
$844K Buy
1,452
+62
+4% +$34.8K 0.53% 49
2023
Q4
$738K Buy
+1,390
New +$673K 0.53% 50

Other funds holding TMO

Aviso Wealth Management's TMO Position: Q1 2026 in Review

Aviso Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 8% in Q1 2026, selling an estimated $68.9K and leaving 1,451 shares worth $713K. The position accounts for 0.32% of the portfolio, ranked #71.

Aviso Wealth Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.11M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aviso Wealth Management held 1,451 shares of Thermo Fisher Scientific worth $713K as of Q1 2026.
  • Aviso Wealth Management sold 127 Thermo Fisher Scientific shares in Q1 2026, an estimated $68.9K.
  • Thermo Fisher Scientific made up 0.32% of Aviso Wealth Management's portfolio in Q1 2026, its #71 holding.
  • Aviso Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Aviso Wealth Management's Thermo Fisher Scientific position peaked at $2.11M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.